Related Experiment Video
Updated: Feb 19, 2026

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
Published on: September 14, 2013
Clostridium difficile infection in the elderly: an update on management
Tomefa E Asempa1, David P Nicolau1
1Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA.
Clostridium difficile infection (CDI) significantly impacts the elderly, increasing with age due to weakened immunity and healthcare exposure. New therapies like monoclonal antibodies and fecal microbiota transplantation offer hope for managing this growing health challenge.
Area of Science:
- Infectious Diseases
- Geriatrics
- Pharmacology
Background:
- Clostridium difficile infection (CDI) poses a significant and increasing burden, particularly in healthcare settings.
- Elderly individuals are disproportionately affected by CDI due to age-related immune decline, increased antibiotic use, and frequent healthcare exposure.
- Two-thirds of healthcare-associated CDIs in the USA occur in patients aged 65 and older, who also face a higher risk of recurrence.
Purpose of the Study:
- To review current management strategies for Clostridium difficile infection (CDI) in the elderly population.
- To identify the merits and gaps in existing therapeutic and preventative approaches for CDI in older adults.
- To highlight the need for expanded strategies to improve outcomes for this high-risk demographic.
Main Methods:
- Comprehensive review of prospective and retrospective studies.
- Inclusion of case reports to illustrate clinical scenarios.
- Analysis of data focusing on the management of CDI in elderly patients.
Main Results:
- Existing treatments for CDI include metronidazole, oral vancomycin, and fidaxomicin, with choices influenced by disease severity, recurrence history, and cost.
- Newer therapeutic advancements include bezlotoxumab, a monoclonal antibody targeting C. difficile toxin B, and fecal microbiota transplantation, particularly for recurrent CDI.
- Effective management requires a multi-faceted approach encompassing prevention, optimized initial treatment, and strategies to mitigate recurrence risk.
Conclusions:
- Addressing the growing burden of CDI in the elderly necessitates innovative and expanded management strategies.
- Optimizing preventative measures and treatment protocols is crucial for improving outcomes in this vulnerable population.
- Further research and clinical implementation of novel therapies are essential to combat CDI effectively in older adults.
Related Concept Videos
Drug Dosing: Geriatric Patients
Urinary Tract Infection IV: Nursing Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management

